A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease
Launched by PURDUE UNIVERSITY · Apr 13, 2022
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Lower-extremity PAD is a manifestation of systemic atherosclerosis associated with increased risk of cardiovascular morbidity and mortality, diminished quality of life, physical functioning and psychological well-being. In 2015, an estimated 236 million people worldwide, most between 65 and 69 years of age, were living with PAD. Home-based leg heat therapy (HT) is emerging as a potential effective and practical treatment to increase leg blood flow and improve walking performance in patients with symptomatic PAD. In the first randomized sham-controlled trial to examine the benefits of superv...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women 60 years or older
- • Resting ankle-brachial index (ABI) of 0.9 or less in at least one leg.
- • Individuals with a resting ABI between 0.91 and 1.00 at baseline will be eligible if their ABI drops by 20% or greater following a heel-rise test.
- Exclusion Criteria:
- • Critical limb ischemia (ischemic rest pain or ischemia-related, non-healing wounds or tissue loss)
- • Prior amputation
- • Exercise tolerance limited by factors other than leg pain (e.g. angina, arthritis, severe lung disease, etc).
- • Recent (\<3 months) lower-extremity revascularization or orthopedic surgery
- • Use of walking aid other than a cane
- • Active cancer
- • Chronic kidney disease (eGFR \<30 by MDRD or Mayo or Cockcroft-Gault formula)
- • Unable to fit into water-circulating trousers
- • A Mini-Mental Status Examination score \<23
- • Impaired thermal sensation in the leg
- • Age lower than 60 yrs
About Purdue University
Purdue University is a renowned research institution dedicated to advancing knowledge and innovation across various fields, including health and medicine. As a clinical trial sponsor, Purdue leverages its extensive academic resources and multidisciplinary expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical standards and regulatory compliance, Purdue University collaborates with healthcare professionals and industry partners to translate research findings into practical applications, ultimately enhancing the quality of care and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
West Lafayette, Indiana, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials